Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Masanori Kukida"'
Autor:
Masatsugu Horiuchi, Hui-Yu Bai, Masaki Mogi, Akinori Higaki, Li-Juan Min, Masanori Kukida, Bao-Shuai Shan, Kana Tsukuda, Hirotomo Nakaoka, Jun Iwanami
Publikováno v:
Stroke. 50
Introduction: Distant organ dysfunction has been highlighted whereby acute or chronic damage in one organ may induce dysfunctions of the other organs such as cardiorenal syndrome. Vascular injury is an important process in various vascular diseases.
Autor:
Akinori Higaki, Li-Juan Min, Jun Iwanami, Hirotomo Nakaoka, Masatsugu Horiuchi, Moe Kawakami, Masaki Mogi, Masanori Kukida, Hui-Yu Bai, Kana Tsukuda, Bao-Shuai Shan, Toshifumi Yamauchi
Publikováno v:
Hypertension. 72
Introduction: Distant organ dysfunction has been highlighted whereby acute or chronic damage in one organ may induce acute or chronic dysfunctions of the other organs such as cardiorenal syndrome. Vascular remodeling is an important process in variou
Autor:
Toshifumi Yamauchi, Kana Tsukuda, Bao-Shuai Shan, Akinori Higaki, Masanori Kukida, Xiao-Li Wang, Jun Iwanami, Li-Juan Min, Moe Kawakami, Masaki Mogi, Masatsugu Horiuchi, Hui-Yu Bai, Hirotomo Nakaoka
Publikováno v:
Stroke. 49
Objective: Accumulating evidences and previous our research suggest that angiotensin II type 2 (AT 2 ) receptor stimulation could contribute to protection against ischemic brain damage. We have cloned ATIP (AT 2 receptor interacting protein) as a pro
Autor:
Jun Iwanami, Masaki Mogi, Xiao-Li Wang, Kana Tsukuda, Akinori Higaki, Masanori Kukida, Hirotomo Nakaoka, Toshifumi Yamauchi, Hui-Yu Bai, Bao-Shuai Shan, Li-Juan Min, Masatsugu Horiuchi
Publikováno v:
Hypertension. 70
Objectives: We reported the preventive effects of angiotensin II type 2 (AT2) receptor stimulation on ischemic brain damage. Moreover, we have cloned ATIP (AT2 receptor interacting protein) as a protein interacting specifically with the C-terminal ta
Autor:
Toshifumi Yamauchi, Masatsugu Horiuchi, Akinori Higaki, Li-Juan Min, Xiao-Li Wang, Jun Iwanami, Kana Tsukuda, Bao-Shuai Shan, Masanori Kukida, Masaki Mogi, Hui-Yu Bai
Publikováno v:
Stroke. 48
Background and Aim: Stroke is known to be causally related with Alzheimer’s disease pathology and amyloid-β (Aβ) deposition has been suggested to induce cerebral amyloid angiopathy resulting in stroke-associated cognitive decline. Angiotensin (An
Autor:
Hirotomo Nakaoka, Bao-Shuai Shan, Akinori Higaki, Xiao-Li Wang, Toshifumi Yamauchi, Kana Tsukuda, Masatsugu Horiuchi, Jun Iwanami, Masanori Kukida, Li-Juan Min, Masaki Mogi, Hui-Yu Bai
Publikováno v:
Stroke. 48
Objective: We previously reported that the ischemic brain area was significantly larger in angiotensin II type 2 (AT 2 ) receptor-deficient mice after middle cerebral artery (MCA) occlusion compared to wild-type mice. We have cloned ATIP (AT 2 recept
Autor:
Akinori Higaki, Li-Juan Min, Masaki Mogi, Masatsugu Horiuchi, Toshifumi Yamauchi, Kana Tsukuda, Hui-Yu Bai, Xiao-Li Wang, Hirotomo Nakaoka, Jun Iwanami, Bao-Shuai Shan, Masanori Kukida
Publikováno v:
Stroke. 47
Introduction: The classical renin-angiotensin system (RAS), known as the angiotensin (Ang) converting enzyme (ACE)/Ang II/Ang II type 1 (AT1) receptor axis, induces various organ damage including cognitive decline. On the other hand, the ACE2/Ang-(1-
Autor:
Jun Iwanami, Masaki Mogi, Kana Tsukuda, Xiao-Li Wang, Akinori Higaki, Masanori Kukida, Hirotomo Nakaoka, Toshifumi Yamauchi, Hui-Yu Bai, Bao-Shuai Shan, Li-Juan Min, Masatsugu Horiuchi
Publikováno v:
Stroke. 47
Introduction: It is well known that activation of angiotensin type 1 (AT1) receptor results in cognitive impairment. In contrast, accumulating evidences suggest that angiotensin II type 2 (AT2) receptor stimulation might prevent cognitive impairment
Autor:
Jun Iwanami, Masaki Mogi, Kana Tsukuda, Xiao-Li Wang, Masanori Kukida, Hirotomo Nakaoka, Toshiyuki Chisaka, Hui-Yu Bai, Bao-Shao Shang, Masatsugu Horiuchi
Publikováno v:
Stroke. 46
Objectives: Recent clinical evidence demonstrated that angiotensin II type 1 receptor blockers (ARBs) were associated with a significant reduction in the incidence and progression of dementia compared with angiotensin converting enzyme inhibitor. The
Autor:
Masaki Mogi, Bao-Shuai Shan, Akinori Higaki, Hirotomo Nakaoka, Li-Juan Min, Masatugu Horiuchi, Masanori Kukida, Jun Iwanami, Toshifumi Yamauchi, Hui-Yu Bai, Kana Tsukuda
Publikováno v:
Journal of Hypertension. 34:e386